CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis
Clinical trial NCT05430412 · UNKNOWN
Trial details
- NCT number
- NCT05430412
- Sponsor
- Adacyte Therapeutics SL
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2024-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.